Phase I Clinical Trial

Our leadership and a proven track record in the effective conduct of Phase I Clinical Trial – specifically Clinical Studies for Phase I-IV trials is reflected in the fact that Lotus Labs has strategic working relationships with reputed hospitals that ensures having access to a large database spanning diverse therapeutic areas..This ensures that we always have access to a large database spanning diverse therapeutic areas to effectively conduct Clinical Trials that would eventually further the prospects of path breaking proprietary diagnostics and therapies.

Lotus Labs has considerable experience in various dosage forms including injectables, oral dosage forms including suspensions, topical preparations, topical patches, inhalers and delayed release formulations.

Our 360° Approach to Clinical Trials Phase I

Phase I Bio equivalence Clinical facilities at Lotus Labs are spread across 2 locations aggregating a capacity of over 194 beds, with separate areas for subject screening and blood draws, pharmacy, state-of-the-art fully equipped ICU’s and tie-up with a multi-specialty hospital in the vicinity to handle emergencies. What’s more for conducting Phase I Clinical Trial, , Lotus Labs has access to a database of over 1000 Hospitals.

At Lotus Labs, our research programs employ the latest study designs in clinical pharmacology, bioanalytical method development and Pharmacokinetic analysis, conducted by a team of experienced and well-trained clinical coordinators and research associates. Our 360° approach to Clinical Trials ensures that sponsors benefit from the entire gamut of services – Feasibility Studies, Volunteer Recruitment & Planning, Clinical Trial Supplies & Management, Project Management, Clinical Monitoring, Bio Statistics and Pharmacy Services – ensuring strict adherence to GCP and other international regulatory requirements.